Right Heart Dysfunction in Heart Failure With Preserved Ejection Fraction: The Impact of Atrial Fibrillation.

[1]  L. Ling,et al.  Right ventricular dysfunction in left‐sided heart failure with preserved versus reduced ejection fraction , 2017, European journal of heart failure.

[2]  P. Leinveber,et al.  Prevalence and Predictors of Early Heart Failure With Preserved Ejection Fraction in Patients With Paroxysmal Atrial Fibrillation. , 2017, Journal of cardiac failure.

[3]  M. Guazzi,et al.  Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction , 2017, European journal of heart failure.

[4]  M. Rienstra,et al.  Measuring Pulmonary Artery Pressures in Heart Failure: A New Useful Diagnostic Tool? , 2017, Circulation.

[5]  I. V. Van Gelder,et al.  Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume. , 2017, JACC. Heart failure.

[6]  Dipak Kotecha,et al.  The Present and FutureReview Topic of the WeekHeart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins , 2016 .

[7]  V. Melenovský,et al.  Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction. , 2016, European heart journal.

[8]  A. Voors,et al.  Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta‐analysis , 2016, European journal of heart failure.

[9]  G. Lewis,et al.  Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial. , 2016, Circulation. Heart failure.

[10]  R. Ristl,et al.  The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics , 2016, European journal of heart failure.

[11]  R. D. de Boer,et al.  Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial. , 2015, European heart journal.

[12]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[13]  V. Melenovský,et al.  Left Atrial Remodeling and Function in Advanced Heart Failure With Preserved or Reduced Ejection Fraction , 2015, Circulation. Heart failure.

[14]  V. Roger,et al.  Right Ventricular Function in Heart Failure With Preserved Ejection Fraction: A Community-Based Study , 2014, Circulation.

[15]  Grace Lin,et al.  Right heart dysfunction in heart failure with preserved ejection fraction. , 2014, European heart journal.

[16]  G. Lewis,et al.  It Is Time to Look at Heart Failure With Preserved Ejection Fraction From the Right Side , 2014, Circulation.

[17]  M. Hoeper,et al.  Atrial flutter and fibrillation in patients with pulmonary hypertension. , 2013, International journal of cardiology.

[18]  W. Paulus,et al.  A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. , 2013, Journal of the American College of Cardiology.

[19]  R. D. de Boer,et al.  Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. , 2013, European heart journal.

[20]  Angelo B. Biviano,et al.  Arrhythmias in pulmonary arterial hypertension. , 2012, Progress in cardiovascular diseases.

[21]  Erland Erdmann,et al.  Clinical Impact of Atrial Fibrillation in Patients with Pulmonary Hypertension , 2012, PloS one.

[22]  P. Platonov,et al.  Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. , 2011, Journal of the American College of Cardiology.

[23]  M. Rienstra,et al.  Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction , 2011, European journal of heart failure.

[24]  D. Sánchez-Quintana,et al.  The importance of atrial structure and fibers , 2009, Clinical anatomy.

[25]  M. Pfeffer,et al.  Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. , 2006, Journal of the American College of Cardiology.

[26]  Andrew P. Kramer,et al.  Functional impact of rate irregularity in patients with heart failure and atrial fibrillation receiving cardiac resynchronization therapy. , 2005, European heart journal.

[27]  S. Cho,et al.  Effects of left atrial compliance on left atrial pressure in pure mitral stenosis , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[28]  M. Alam,et al.  Cardioversion of atrial fibrillation and its effect on right ventricular function as assessed by tricuspid annular motion. , 1999, The American journal of cardiology.

[29]  J. Concato,et al.  A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.

[30]  J. Concato,et al.  Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. , 1995, Journal of clinical epidemiology.